"N Engl J Med"[journal] 检索结果

501. Targeting the Effect of VEGF in Diabetic Macular Edema.

来源: N Engl J Med. 2015年373卷10期982页

502. Vasopressin Antagonists.

作者: Frédéric Vandergheynst.;Fabrice Gankam Kengne.;Guy Decaux.
来源: N Engl J Med. 2015年373卷10期980-1页

503. Vasopressin Antagonists.

作者: Tomas Berl.
来源: N Engl J Med. 2015年373卷10期981页

504. Therapeutic Hypothermia in Children.

作者: Matthias L Riess.;Tom P Aufderheide.;Demetris Yannopoulos.
来源: N Engl J Med. 2015年373卷10期979-80页

505. Therapeutic Hypothermia in Children.

作者: Alon Geva.;Robert C Tasker.;Adrienne G Randolph.
来源: N Engl J Med. 2015年373卷10期979页

506. Therapeutic Hypothermia in Children.

作者: Frank W Moler.;Richard Holubkov.;J Michael Dean.
来源: N Engl J Med. 2015年373卷10期980页

507. Follow-up of Glycemic Control and Cardiovascular Outcomes in Type 2 Diabetes.

作者: Naga V Pothineni.;Jawahar L Mehta.
来源: N Engl J Med. 2015年373卷10期977-8页

508. Follow-up of Glycemic Control and Cardiovascular Outcomes in Type 2 Diabetes.

作者: Roy E Fried.
来源: N Engl J Med. 2015年373卷10期977页

509. Follow-up of Glycemic Control and Cardiovascular Outcomes in Type 2 Diabetes.

作者: Rodney A Hayward.;Peter D Reaven.;Nicholas V Emanuele.; .
来源: N Engl J Med. 2015年373卷10期978页

510. Type 2 Diabetes, SGLT2 Inhibitors, and Glucose Secretion.

作者: Andrew T Hattersley.;Bernard Thorens.
来源: N Engl J Med. 2015年373卷10期974-6页

511. Forbidden and Permitted Statements about Medications--Loosening the Rules.

作者: Jerry Avorn.;Ameet Sarpatwari.;Aaron S Kesselheim.
来源: N Engl J Med. 2015年373卷10期967-73页

512. Treating Myeloproliferation--On Target or Off?

作者: Mary Armanios.;Carol W Greider.
来源: N Engl J Med. 2015年373卷10期965-6页

513. CLINICAL PROBLEM-SOLVING. On the Nose.

作者: Marwah Abdalla.;Paul E Sax.;Arash Mostaghimi.;Amy Leigh Miller.;Joseph Loscalzo.
来源: N Engl J Med. 2015年373卷10期955-61页

514. IMAGES IN CLINICAL MEDICINE. Gastric Pneumatosis.

作者: Ann-Christina Brady.;Patrick A Dillon.
来源: N Engl J Med. 2015年373卷10期954页

515. Prenatal Factors in Singletons with Cerebral Palsy Born at or near Term.

作者: Karin B Nelson.;Eve Blair.
来源: N Engl J Med. 2015年373卷10期946-53页

516. In-Flight Medical Emergencies during Commercial Travel.

作者: Jose V Nable.;Christina L Tupe.;Bruce D Gehle.;William J Brady.
来源: N Engl J Med. 2015年373卷10期939-45页

517. Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy.

作者: Christian Templin.;Jelena R Ghadri.;Johanna Diekmann.;L Christian Napp.;Dana R Bataiosu.;Milosz Jaguszewski.;Victoria L Cammann.;Annahita Sarcon.;Verena Geyer.;Catharina A Neumann.;Burkhardt Seifert.;Jens Hellermann.;Moritz Schwyzer.;Katharina Eisenhardt.;Josef Jenewein.;Jennifer Franke.;Hugo A Katus.;Christof Burgdorf.;Heribert Schunkert.;Christian Moeller.;Holger Thiele.;Johann Bauersachs.;Carsten Tschöpe.;Heinz-Peter Schultheiss.;Charles A Laney.;Lawrence Rajan.;Guido Michels.;Roman Pfister.;Christian Ukena.;Michael Böhm.;Raimund Erbel.;Alessandro Cuneo.;Karl-Heinz Kuck.;Claudius Jacobshagen.;Gerd Hasenfuss.;Mahir Karakas.;Wolfgang Koenig.;Wolfgang Rottbauer.;Samir M Said.;Ruediger C Braun-Dullaeus.;Florim Cuculi.;Adrian Banning.;Thomas A Fischer.;Tuija Vasankari.;K E Juhani Airaksinen.;Marcin Fijalkowski.;Andrzej Rynkiewicz.;Maciej Pawlak.;Grzegorz Opolski.;Rafal Dworakowski.;Philip MacCarthy.;Christoph Kaiser.;Stefan Osswald.;Leonarda Galiuto.;Filippo Crea.;Wolfgang Dichtl.;Wolfgang M Franz.;Klaus Empen.;Stephan B Felix.;Clément Delmas.;Olivier Lairez.;Paul Erne.;Jeroen J Bax.;Ian Ford.;Frank Ruschitzka.;Abhiram Prasad.;Thomas F Lüscher.
来源: N Engl J Med. 2015年373卷10期929-38页

The natural history, management, and outcome of takotsubo (stress) cardiomyopathy are incompletely understood.

518. Telomerase Inhibitor Imetelstat in Patients with Essential Thrombocythemia.

作者: Gabriela M Baerlocher.;Elisabeth Oppliger Leibundgut.;Oliver G Ottmann.;Gary Spitzer.;Olatoyosi Odenike.;Michael A McDevitt.;Alexander Röth.;Michael Daskalakis.;Bart Burington.;Monic Stuart.;David S Snyder.
来源: N Engl J Med. 2015年373卷10期920-8页

Imetelstat, a 13-mer oligonucleotide that is covalently modified with lipid extensions, competitively inhibits telomerase enzymatic activity. It has been shown to inhibit megakaryocytic proliferation in vitro in cells obtained from patients with essential thrombocythemia. In this phase 2 study, we investigated whether imetelstat could elicit hematologic and molecular responses in patients with essential thrombocythemia who had not had a response to or who had had unacceptable side effects from prior therapies.

519. A Pilot Study of the Telomerase Inhibitor Imetelstat for Myelofibrosis.

作者: Ayalew Tefferi.;Terra L Lasho.;Kebede H Begna.;Mrinal M Patnaik.;Darci L Zblewski.;Christy M Finke.;Rebecca R Laborde.;Emnet Wassie.;Lauren Schimek.;Curtis A Hanson.;Naseema Gangat.;Xiaolin Wang.;Animesh Pardanani.
来源: N Engl J Med. 2015年373卷10期908-19页

Current drugs for myeloproliferative neoplasm-associated myelofibrosis, including Janus kinase (JAK) inhibitors, do not induce complete or partial remissions. Imetelstat is a 13-mer lipid-conjugated oligonucleotide that targets the RNA template of human telomerase reverse transcriptase.

520. Perennial Health Care Reform--The Long Dutch Quest for Cost Control and Quality Improvement.

作者: Ewout van Ginneken.
来源: N Engl J Med. 2015年373卷10期885-9页

结果排序

文献格式

出版时间

出版类型

出版语言